Skip to main content

Advertisement

SpringerLink
Log in

Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63–74. doi:10.1016/S1474-4422(10)70253-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, Gleichman AJ, Balice-Gordon R, Rosenfeld MR, Lynch D, Graus F, Dalmau J (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 13:167–177. doi:10.1016/S1474-4422(13)70282-5

    Article  CAS  PubMed  Google Scholar 

  3. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655–1667. doi:10.1093/brain/awq113

    Article  PubMed  PubMed Central  Google Scholar 

  4. Frechette ES, Zhou L, Galetta SL, Chen L, Dalmau J (2011) Prolonged follow-up and CSF antibody titers in a patient with anti-NMDA receptor encephalitis. Neurology 76(7 Suppl 2):S64–S66. doi:10.1212/WNL.0b013e31820c34de

    Article  PubMed  Google Scholar 

  5. Prüss H, Dalmau J, Harms L, Höltje M, Ahnert-Hilger G, Borowski K, Stoecker W, Wandinger KP (2010) Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 75:1735–1739. doi:10.1212/WNL.0b013e3181fc2a06

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Euroimmun for the unpaid donation of anti-NMDAR kit.

Author information

Authors and Affiliations

  1. Department of Neurosciences, Biomedicine and Movement, Neurology Unit, University of Verona, Verona, Italy

    S. Mariotto, A. Farinazzo, S. Monaco & S. Ferrari

  2. Neurology IV. Neuroimmunology and Neuromuscular Diseases Unit, Foundation IRCCS Neurological Institute “Carlo Besta”, Milan, Italy

    F. Andreetta

Authors
  1. S. Mariotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Andreetta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Farinazzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Monaco
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Ferrari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Ferrari.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Informed consent was obtained from the patient described in this report.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mariotto, S., Andreetta, F., Farinazzo, A. et al. Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis. Neurol Sci 38, 1523–1524 (2017). https://doi.org/10.1007/s10072-017-2958-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-017-2958-x

Keywords

Search

Navigation